Miller GJ - Search Results

1

A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines.

Hedlund TE, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Prostate. 1994 May;24(5):221-8. doi: 10.1002/pros.2990240502. Prostate. 1994. PMID: 7513416

2

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.

Hedlund TE, Johannes WU, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Prostate. 2003 Jan 1;54(1):68-78. doi: 10.1002/pros.10137. Prostate. 2003. PMID: 12481257

3

Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.

Miller GJ, Stapleton GE, Hedlund TE, Moffat KA. Miller GJ, et al. Clin Cancer Res. 1995 Sep;1(9):997-1003. Clin Cancer Res. 1995. PMID: 9816072

4

Three-dimensional spheroid cultures of human prostate cancer cell lines.

Hedlund TE, Duke RC, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Prostate. 1999 Nov 1;41(3):154-65. doi: 10.1002/(sici)1097-0045(19991101)41:3<154::aid-pros2>3.0.co;2-m. Prostate. 1999. PMID: 10517873

5

Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31.

Moffatt KA, Johannes WU, Hedlund TE, Miller GJ. Moffatt KA, et al. Among authors: miller gj. Cancer Res. 2001 Oct 1;61(19):7122-9. Cancer Res. 2001. PMID: 11585744

6

The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.

Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P. Miller GJ, et al. Cancer Res. 1992 Feb 1;52(3):515-20. Cancer Res. 1992. PMID: 1370648

7

Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.

Hedlund TE, Moffatt KA, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Endocrinology. 1996 May;137(5):1554-61. doi: 10.1210/endo.137.5.8612485. Endocrinology. 1996. PMID: 8612485

8

Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.

Hedlund TE, Moffatt KA, Miller GJ. Hedlund TE, et al. Among authors: miller gj. J Steroid Biochem Mol Biol. 1996 Jun;58(3):277-88. doi: 10.1016/0960-0760(96)00030-1. J Steroid Biochem Mol Biol. 1996. PMID: 8836163

9

Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage.

Hedlund TE, Duke RC, Schleicher MS, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Prostate. 1998 Jul 1;36(2):92-101. doi: 10.1002/(sici)1097-0045(19980701)36:2<92::aid-pros4>3.0.co;2-g. Prostate. 1998. PMID: 9655261

10

Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.

Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Clin Cancer Res. 1997 Aug;3(8):1331-8. Clin Cancer Res. 1997. PMID: 9815816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters